UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

An alternative cannulation approach for venovenous extracorporeal membrane oxygenation in children for long-term ambulatory support

The Journal of thoracic and cardiovascular surgery, 2018-07, Vol.156 (1), p.e13-e14

2018

Volltextzugriff (PDF)

High-Dose Oral N-Acetylcysteine, a Glutathione Prodrug, Modulates Inflammation in Cystic Fibrosis

Proceedings of the National Academy of Sciences - PNAS, 2006-03, Vol.103 (12), p.4628-4633

2006

Volltextzugriff (PDF)

Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways

Proceedings of the National Academy of Sciences - PNAS, 2008-03, Vol.105 (11), p.4335-4339

2008

Volltextzugriff (PDF)

Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs

Proceedings of the National Academy of Sciences - PNAS, 2009-04, Vol.106 (14), p.5779-5783

2009

Volltextzugriff (PDF)

Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: A two-part clinical study

Human gene therapy, 2003-07, Vol.14 (11), p.1079-1088

2003

Volltextzugriff (PDF)

Lung clearance index is sensitive to small airway disease in pediatric lung transplant recipients

The Journal of heart and lung transplantation, 2017-09, Vol.36 (9), p.980-984

2017

Volltextzugriff (PDF)

Resistin is elevated in cystic fibrosis sputum and correlates negatively with lung function

Journal of cystic fibrosis, 2019-01, Vol.18 (1), p.64-70

2019

Volltextzugriff (PDF)

Current State of Pediatric Lung Transplantation

Lung, 2015-10, Vol.193 (5), p.629-637

2015

Volltextzugriff (PDF)

Auto‐inflammation and auto‐immunity pathways are associated with emergence of BOS in pediatric lung transplantation

Pediatric transplantation, 2022-06, Vol.26 (4), p.e14247-n/a

2022

Volltextzugriff (PDF)

Multicenter Evaluation of Infant Lung Function Tests as Cystic Fibrosis Clinical Trial Endpoints

American journal of respiratory and critical care medicine, 2010-12, Vol.182 (11), p.1387-1397

2010

Volltextzugriff (PDF)

Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis

The European respiratory journal, 2013-12, Vol.42 (6), p.1545-1552

2013

Volltextzugriff (PDF)

A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies

Human gene therapy, 2002-07, Vol.13 (11), p.1349-1359

2002

Volltextzugriff (PDF)

Safety and Biological Efficacy of an Adeno-Associated Virus Vector-Cystic Fibrosis Transmembrane Regulator (AAV-CFTR) in the Cystic Fibrosis Maxillary Sinus

The Laryngoscope, 1999-02, Vol.109 (2), p.266-274

1999

Volltextzugriff (PDF)

Hemothorax in a child as a result of costal exostosis

Pediatrics (Evanston), 1994-03, Vol.93 (3), p.523

1994

Volltextzugriff (PDF)

Lung Clearence Index is Sensitive to Small Airway Disease in Pediatric Lung Transplant Recipients

The Journal of heart and lung transplantation, 2017

2017

Volltextzugriff (PDF)

High-dose oral IV-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis

Proceedings of the National Academy of Sciences - PNAS, 2006-03, Vol.103 (12), p.4628

2006

Volltextzugriff (PDF)

In vivo model of adeno-associated virus vector persistence and rescue

Journal of Virology, 1996-05, Vol.70 (5), p.3235-3241

1996

Volltextzugriff (PDF)

A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis

Human gene therapy, 1998-04, Vol.9 (6), p.889-909

1998

Volltextzugriff (PDF)

Gene therapy vectors as drug delivery systems

Clinical pharmacokinetics, 1995-03, Vol.28 (3), p.181-189

1995

Volltextzugriff (PDF)

A Phase I/II Study of tgAAV-CF for the Treatment of Chronic Sinusitis in Patients with Cystic Fibrosis. Stanford University, Stanford, California

Human gene therapy, 1998-04, Vol.9 (6), p.889-909

1998

Volltextzugriff (PDF)

Ecological and cultural factors underlying the global distribution of prejudice

PloS one, 2019-09, Vol.14 (9), p.e0221953-e0221953

2019

Volltextzugriff (PDF)

Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure

The New England journal of medicine, 2019-02, Vol.380 (6), p.539-548

2019

Volltextzugriff (PDF)

Variation in genome-wide mutation rates within and between human families

Nature genetics, 2011-07, Vol.43 (7), p.712-714

2011

Volltextzugriff (PDF)

Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition

Molecular cancer therapeutics, 2005-01, Vol.4 (1), p.101-112

2005

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(37)
Humans
(36)
Male
(21)
Female
(17)
Biological And Medical Sciences
(14)
Adult
(10)
Child
(9)
Medical Sciences
(9)
Middle Aged
(9)
Adolescent
(8)
Respiratory System
(7)
Animals
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Neurosciences
(6)
Neurosciences & Neurology
(6)
Pediatrics
(6)
Child, Preschool
(5)
Clinical Neurology
(5)
Cystic Fibrosis
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An alternative cannulation approach for venovenous extracorporeal membrane oxygenation in children for long-term ambulatory support

High-Dose Oral N-Acetylcysteine, a Glutathione Prodrug, Modulates Inflammation in Cystic Fibrosis

Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways

Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs

Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: A two-part clinical study

Lung clearance index is sensitive to small airway disease in pediatric lung transplant recipients

Resistin is elevated in cystic fibrosis sputum and correlates negatively with lung function

Current State of Pediatric Lung Transplantation

Auto‐inflammation and auto‐immunity pathways are associated with emergence of BOS in pediatric lung transplantation

Multicenter Evaluation of Infant Lung Function Tests as Cystic Fibrosis Clinical Trial Endpoints

Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis

A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies

Safety and Biological Efficacy of an Adeno-Associated Virus Vector-Cystic Fibrosis Transmembrane Regulator (AAV-CFTR) in the Cystic Fibrosis Maxillary Sinus

Hemothorax in a child as a result of costal exostosis

Lung Clearence Index is Sensitive to Small Airway Disease in Pediatric Lung Transplant Recipients

High-dose oral IV-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis

In vivo model of adeno-associated virus vector persistence and rescue

A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis

Gene therapy vectors as drug delivery systems

A Phase I/II Study of tgAAV-CF for the Treatment of Chronic Sinusitis in Patients with Cystic Fibrosis. Stanford University, Stanford, California

Ecological and cultural factors underlying the global distribution of prejudice

Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure

Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity

Variation in genome-wide mutation rates within and between human families

Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition

Suchergebnisse filtern